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ABSTRACT 
AIM OF THE STUDY 
To study the effect of dexmedetomidine in attenuating the arterial pressure 
increase due to pneumoperitoneum in patients posted for elective laparoscopic 
cholecystectomy 
AUTHOR : Prof.S.Gunasekaran,M.D.,D.A.,DNB 
BACKGROUND 
 Dexmedetomidine is a alpha 2 adrenoreceptor agoinst being increasingly 
used in anaesthesia and critical care as they not only decrease the sympathetic tone 
and attenuate the stress responses to anesthesia and surgery, but also causes 
sedation and analgesia. Already Clonidine, a similar alpha 2 agonist was proved in 
attenuating  arterial pressure increase during laproscopic  surgeries. So we 
investigated whether IV dexmedetomidine attenuates the hemodynamic stress 
response to pneumoperitoneum by changing neurohormonal responses during 
laproscopic  cholecystectomy 
MATERIAL AND METHODS 
 After obtaining ethical committee approval from Govt Kilpauk Medical 
College, 40 patients with average of 18-60 years undergoing elective laproscopic 
cholecystectomy are to be randomized into two groups of 20 each. Patients to  be 
premedicated with glycopyrrolate 0.2 mg IM one hour before surgery and fentanyl 
2mcg/kg IV before induction. The trachea  intubated after induction of anaesthesia 
with propofol 1.5- 2 mg/kg and vecuronium 0.1 mg/kg.  Anaesthesia maintained 
with 1-1.5% sevoflurane and 2:4  O2/N2O at 6lit/min. After induction study group 
to receive IV dexmedetomidine 0.5 mcg/kg bolus followed by 0.5μg/kg/hr infusion 
and control group to receive  normal saline at same infusion rate. After completion 
of surgery, pneumoperitoneum deflated slowly and after the patient had adequate 
respiratory attempts patient reversed with glycopyrrolate and neostigmine IV. 
  Arterial pressure and heart rate are measured before induction, pre 
pneumoperitoneum, at pneumoperitoneum(P0), at 5 min , 10 min, 20 min, 30 min 
after pneumoperitoneum and post surgery.Serum noradrenaline samples are taken 
pre pneumperitoneum and at 10 minute pneumoperitoneum. 
 
RESULTS 
We observed, that the systolic, diastolic and mean arterial pressure increased 
abruptly after induction of pneumoperitoneum  and this response sustained during 
the entire pneumoperitoneum period in the control group( group A). In the 
dexmedetomidine group( group B) hemodynamic responses to the induction of 
pneumoperitoneum were effectively blunted and the heart rate and blood pressure 
levels when compared to the control group( group A). In the control group (group 
A) the 10 minute serum noradrenaline values were significantly higher than the pre 
pneumoperitoneal values  suggesting that all these hemodynamic changes are due 
to release of catecholamines. In the study group (group B),  the noradrenaline 
levels taken 10 minutes after induction of pneumoperitoneum  were significantly 
not increased when compared with the pre pneumoperitoneal values  suggesting 
that dexmedetomidine effectively suppressed the hemodynamic responses by its 
central sympatholytic action. 
CONCLUSION 
We conclude that intravenous administration of dexmedetomidine as an 
adjunct before induction of pneumoperitoneum  in laparoscopic cholecyctectomy 
effectively attenuates  the arterial pressure increase due to pneumoperitoneal 
response.  
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INTRODUCTION 
Surgical procedures and anaesthetic techniques and gadgets have 
improved over decades with recent advances and there is drastic fall in the 
mortality and morbidity. As a result of that there is consequent reduction in 
health care cost. With the invent of better equipment and modern facilities, 
along with increased knowledge and better understanding of anatomy, 
physiology and pathophysiology, has lead to the development of laparoscopy 
for diagnostic and operative procedures. The pneumoperitoneum and the patient 
positions required for laparoscopy induce a sequence of pathophysiologic 
changes in terms of increased intra abdominal pressure (IAP) and systemic CO2 
absorption that can complicate anaesthesia. Hence better understanding of the 
CO2 pneumoperitoneum in laparoscopy is important for the anesthesiologist for 
better management of the patient.  
Moreover with the advancements in medical field there is increase in the 
life expectancy. So as anaesthesiologist, we are expected to anaesthetise elderly 
patients with associated co morbid conditions, like diabetes, hypertension, 
Ischemic heart disease etc. So understanding the physiology of CO2 
pneumoperitoneum becomes very much essential. 
The multiple benefits like reduced hospital stay, post operative pain, 
respiratory complications and less cost reported after laparoscopy explains its 
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increasing use and has now become the standard technique for cholecystectomy. 
However, the CO2 pneumoperitoneum required for laparoscopy results in 
pathophysiologic changes particularly in cardiovascular system and respiratory 
system like 10-30 % decrease in cardiac output, significant  increase in arterial 
pressure and systemic vascular resistances occurring soon after the beginning of 
intra abdominal insufflation, with no significant changes in heart rate (HR).Both 
mechanical and neurohumoral factors contribute to these hemodynamic 
changes. There is an increase in catecholamines, prostaglandins, renin and 
vasopressin levels. 
There are lots of anaesthetic methods and anaesthetic drugs have been 
used for attenuating the response associated with pneumoperitoneum. It has 
been already studied that Clonidine, alpha2-adrenergic agonists effectively 
attenuates the pneumoperitoneal response of the laparoscopy. Recently, 
dexmedetomidine is another drug of same family but more specific than 
Clonidine with better safety profile.  We therefore tested the hypothesis, that 
dexmedetomidine might attenuate the hemodynamic changes induced by 
increased intra abdominal pressure due to CO2 pneumoperitoneum by reducing 
release of noradrenaline. 
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PATHOPHYSIOLOGY OF CARBON DIOXIDE 
PNEUMOPERITONEUM  
HISTORY OF LAPAROSCOPY 
In the year 1901, George Kelling first introduced CO2 pneumoperitoneum 
for laparoscopic surgeries. Till 1970s laparoscopy was done only for diagnostic 
purposes. Later in 1970 therapeutic procedure was started with laparoscopy in 
gynecology like laparoscopic sterilisation. In 1990s laparoscopy was used for 
cholecystectomy. With further technical advancement, laparoscopy is used for 
many abdominal surgeries. 
PHYSIOLOGIC EFFECTS: 
An important step in all laparoscopy is creation of pneumoperitoneum 
that is insufflation  of gas into the peritoneal cavity for better visualisation of the 
abdominal contents. Pneumoperitoneum induce both mechanical and 
physiological changes in various system in the body especially in 
cardiovascular, respiratory and peripheral vascular system. The systems include  
1. •Cardiovascular system 
2. • Respiratory system 
3. • Renal system 
4. • Gastrointestinal system 
5. • Peripheral vascular system 
10 
 
CHANGES IN CARDIOVASCULAR SYSTEM 
Peritoneal insufflation to IAPs higher than 10 mm Hg induce significant 
alterations of hemodynamics of the patient. The changes in the cardiovascular 
system includes decrease in cardiac output, increased arterial pressures, and 
elevations of systemic and vascular resistances. Heart rates remain unchanged 
or increased only slightly. The changes in cardiac output either increase or 
decrease, is proportional to the increase in IAP. These changes might be caused 
by differences in rates of CO2 insufflation, IAP, degree of patient tilt, time 
intervals between insufflation and collection of data, techniques used to assess 
hemodynamics, and anesthetic techniques. However, most studies have shown a 
fall of cardiac output (10% to 30%) during peritoneal insufflation whether the 
patient was placed in the head-down
 (1)
 or head-up position.
(2)
 
The mechanism for decrease in cardiac output is multifactorial. A 
decrease in venous return is observed after a transient increase in venous return 
at low IAPs (<10 mm Hg).
 
 Increased IAP results in IVC compression, thereby 
causing venous stasis in the legs, reducing the venous return and preload. 
 
Transesophageal echocardiography showed reduction in LVEDV (left 
ventricular end-diastolic volume) during pneumoperitoneum thereby reasoning 
the decrease in cardiac output is due to decrease in venous return.
(3)
 Cardiac 
filling pressures, however, rise during peritoneal insufflations is due to increase 
in intra thoracic pressure accompanying to CO2 pneumoperitoneum. Hence right 
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atrial pressure and pulmonary artery occlusion pressure can no longer be 
considered reliable indices of cardiac filling pressures during 
pneumoperitoneum. The fact that atrial natriuretic peptide concentrations 
remain low despite increased pulmonary capillary occlusion pressure during 
pneumoperitoneum further suggests that abdominal insufflation interferes with 
venous return.
(4) 
By increasing the circulating volume (preloading) before 
induction of CO2 pneumoperitoneum, the decrease in venous return and cardiac 
output can be attenuated. Increased filling pressures can be achieved by fluid 
pre loading or slight head-down position of the patient before peritoneal 
insufflation, by preventing the pooling of blood with intermittent sequential 
pneumatic compression device or by wrapping the legs with elastic bandages.
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The ejection fraction of the left ventricle, assessed by echocardiography, 
does not appear to decrease significantly when IAP increases to 12 mm Hg.
 
 
However, all studies describe an increased systemic vascular resistance during 
the existence of the pneumoperitoneum. This increase in afterload is not due to 
reflex sympathetic response to decreased cardiac output.
 
 Although the normal 
heart tolerates increases in afterload under physiologic conditions, the increases 
in afterload produced by the presence of a pneumoperitoneum can be 
deleterious to cardiac patients. 
The increase in systemic vascular resistance is affected by patient 
position. The Trendelenburg position attenuates this increase;
(1) 
the head-up 
position aggravates it.
(2)
 The increase in systemic vascular resistance can be 
corrected by the administration of vasodilating anesthetic agents, such as 
isoflurane or sevoflurane, or direct acting vasodilating drugs, like  nitroglycerin 
or nicardipine ,or centrally acting sympatholytic drugs like Clonidine. 
The increase in systemic vascular resistance is thought to be mediated by 
mechanical and neurohumoral factors.
  
The alterations in the hemodynamic 
parameters returns to normal baseline values after several minutes, suggesting 
involvement of neurohormonal factors. Catecholamines, the renin-angiotensin 
system, and especially vasopressin are all released during the presence of the 
CO2 pneumoperitoneum and may contribute to increasing the afterload.
(5) 
However, only the time course of vasopressin release parallels that of the 
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increase in systemic vascular resistance.
(5)
 Increases in plasma vasopressin 
concentrations correlate with changes in intrathoracic pressure and transmural 
right atrial pressure. Mechanical stimulation of peritoneal receptors also results 
in increased vasopressin release, systemic vascular resistance, and arterial 
pressure.
(6) 
However, whether increasing IAP to 14 mm Hg is sufficient to 
stimulate these mechanical receptors is not clear. The increase in systemic 
vascular resistance also explains why the arterial pressure increases but the 
cardiac output falls. Use of α2-adrenergic agonists such as Clonidine
(7)
 or 
dexmedetomidine and of β-blocking agents significantly reduces hemodynamic 
changes and anesthetic requirements. Use of high doses of remifentanil almost 
completely prevents the hemodynamic changes. 
CHANGES IN RESPIRATORY SYSTEM 
VENTILATORY CHANGES  
CO2 pneumoperitoneum decreases thoracopulmonary compliance by 30% 
to 50% in healthy and obese patients.
(8) 
Reduction in functional residual 
capacity and development of basal atelectasis due to elevation of  diaphragm
 
and changes in the distribution of pulmonary ventilation and perfusion from 
increased airway pressure can be expected. However, increasing IAP to 14 mm 
Hg with the patient in a 10- to 20-degree head-up or head-down position does 
14 
 
not have significant effect on physiological dead space or shunt fraction in 
patients without cardiovascular problems. 
INCREASE IN THE PARTIAL PRESSURE OF ARTERIAL CO2 
During uneventful CO2 pneumoperitoneum, the partial pressure of arterial 
carbon dioxide (Pa CO2) progressively increases to reach a plateau 15 to 30 
minutes after the beginning of CO2 insufflation in patients under controlled 
mechanical ventilation during gynecologic laparoscopy in the Trendelenburg 
position or during laparoscopic cholecystectomy in the head-up position. After 
that plateau period any further increase in PaCO2  is independent of or related to 
CO2 insufflation and search for other causes such as CO2 subcutaneous 
emphysema has to be thought. The increase in Pa CO2 depends on the IAP.
 
During laparoscopy with local anesthesia, Pa CO2 remains unchanged but 
minute ventilation significantly increases due to CO2. Capnography and pulse 
oximetry provide reliable monitoring of PaCO2 and arterial oxygen saturation in 
healthy patients and in the absence of acute intraoperative disturbances. 
The increase of PaCO2 is multifactorial   and the various reasons attributed are : 
 absorption of CO2 from the peritoneal cavity,  
 mechanical compression of the abdominal contents, patient 
position and controlled ventilation can cause impairment of 
pulmonary ventilation and perfusion.  
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Studies have observed that there is increase in Pa CO2  levels mainly when CO2 
is used as inflating gas and not when nitrous oxide (N2O) or helium is used as 
inflating gas suggesting that the main mechanism of the increased Pa CO2 
during CO2 pneumoperitoneum is absorption of CO2 and primarily due to 
mechanical ventilatory repercussions of increased IAP. 
(9) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
↑ IAP 
↑ cephalad shift 
of diaphragm 
↑ intra thoracic 
pressure 
Paradoxic 
diaphragm motion 
Alveolar collapse ↑ PAWP 
↓ TV 
↑Ve & work of breathing 
↑ CO2 
Hypercapnia  
↑ RR 
↓ FRC 
↓chestwall 
compliance 
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Accordingly, direct measurement of CO2 elimination V CO2 using a 
metabolic monitor combined with investigation of gas exchange showed a 20% 
to 30% increase of V CO2 without significant changes in physiologic dead space 
in healthy patients undergoing pelvic laparoscopy (IAP of 12 to 14 mm Hg) in 
the head-down position
 
 or laparoscopic cholecystectomy in the head-up 
position.
 
Mismatched ventilation and pulmonary perfusion can result from the 
position of the patient and from the increased airway pressures associated with 
abdominal distension. 
CHANGES IN PERIPHERAL VASCULAR SYSTEM
 
Increased IAP and the head-up position result in stasis of blood in the 
lower limbs. Blood flow through femoral vein decreases progressively with 
increasing IAP, and no adaptation to the reduced femoral venous outflow 
occurs, even during prolonged procedures thereby predisposing the patient to 
the development of thromboembolic complications. Although cases of 
thromboembolism have been reported in the literature, there is no actual 
increase in incidence during laparoscopy. 
 
 
 
 
 
↓vascular resistance 
      Venous stasis ↑ risk of DVT Reverse trendenlenburg 
↑IAP 
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CHANGES IN RENAL SYSTEM 
The effect of CO2 pneumoperitoneum on renal function has also been 
investigated.  During laparoscopic cholecystectomy when compared to open 
cholecycstectomy  there is less than 50% decrease in  baseline values of  renal 
plasma flow, glomerular filtration rate and urine output. Urine output 
significantly increases after deflation. 
 
 
 
 
 
CHANGES IN HEPATIC SYSTEM 
Controversy exists regarding the effect of the CO2 pneumoperitoneum on 
splanchnic and hepatic blood flow. A significant reduction was reported in 
animal and humans. However, others have not observed any significant 
changes. Blobner and coworkers,
(10)
 comparing CO2 pneumoperitoneum and air 
pneumoperitoneum in pigs, observed a reduction in splanchnic blood flow 
during air pneumoperitoneum but not during CO2 pneumoperitoneum. They 
↑IAP 
↓ERPF ↓GFR 
↑CO2 
RAAS 
↓urine output 
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suggest that the direct splanchnic vasodilating effect of CO2 may counteract the 
mechanical effect of increased IAP. 
 
 
 
 
 
 
 
 
 
CHANGES IN CENTRAL NERVOUS SYSTEM 
Cerebral blood flow increases during CO2 pneumoperitoneum in response 
to the increased PaCO2.
(11)
When normocarbia is maintained, pneumoperitoneum 
combined with the head-down position does not cause any change in 
intracranial dynamics. Intracranial pressure nevertheless rises during CO2 
pneumoperitoneum, independently of changes in PaCO2, in pigs with 
preoperative induced intracranial hypertension or normal intracranial pressure
 
 
and in children with ventriculoperitoneal shunts. Intraocular pressure is not 
affected by pneumoperitoneum in women with no preexisting eye disease. In an 
↑IAP 
↓portal blood 
flow 
↓hepatic 
artery flow 
↓hepatic perfusion 
↑LFT 
↓perfusion to bowel 
↓intestinal& gastric pH 
↓splanchanic  blood 
flow 
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animal model of glaucoma, pneumoperitoneum only slightly increases 
intraocular pressure. 
POSITION RELATED CHANGES 
Patient positioning depends on the surgical site; trendelenburg position is 
used for pelvic and lower abdominal surgery, reverse trendelenburg position is 
used for upper abdominal surgery. These positions can cause changes in the 
hemodynamics that can have effect on the organ system. These positional 
changes will add up to the changes induced by laparoscopy thereby 
complicating the clinical scenario. So in laparoscopy, position of the patient 
definitely have an impact on the following  patient hemodynamics. 
CARDIOVASCULAR EFFECTS  
In clinically normal subjects, the head-down position or the trendelenburg  
causes an increase in venous return and so preload increases and cardiac output 
increases. The increase in the cardiac output activates the baroreceptor reflex 
thus causing vasodilatation and bradycardia. However these changes caused by 
the position during laparoscopy does not have any significant change in 
hemodynamics in a normal healthy adult because in general anaesthesia these 
reflexes are blunted.
(2)
 But these changes can lead to deleterious effects on 
patients who have poor cardio respiratory reserve.  
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The Trendelenburg position or the head low position causes passive 
venous congestion in the cerebral circulation and can cause in elevation of 
intraocular pressure and this may be deleterious in patients with angle closure 
glaucoma. But the advantage of this position is that it decreases the 
intravascular pressure in the lower part of the body like in pelvic organs and 
reducing the blood loss. But due to decreased intravascular pressure the chances 
of embolism is increased. 
With the head-up position or reverse trendelenburg position, there is a 
decrease in venous return and thereby cardiac output and the mean arterial 
pressure decreases.
  
Since pneumoperitoneum induced by laparoscopy also 
causes decrease in the cardiac output, changes in position will add up these 
changes. So more the angulations of the head up more will be the fall in cardiac 
output. This may not have much effect on a normal adult but will have 
deleterious effects in cardiac patients. 
Lithotomy position may aggravate the hemodynamic changes by 
decreasing the venous return and this may be aggravated in head up position. 
Because pneumoperitoneum can further cause pooling of blood in the legs, any 
other factor decreasing the venous return and contributing to circulatory 
dysfunction should be avoided. Precautions such as supporting the legs, 
modified lithotomy, adequate padding on the popliteal space, pneumatic 
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compression decompression device and avoiding tight strapping of legs should 
be taken. 
RESPIRATORY CHANGES  
The head-down position or tredenlenburg position can cause lung 
atelectasis of basal segments. Steep head-down position causes decrease in total 
lung volume, functional residual capacity and the pulmonary compliance. In 
healthy patients these changes does not have any major change in 
hemodynamics and have significant effect on elderly patient or obese patients. 
The head-up position is considered to be more favourable to respiration. 
NERVE INJURY  
Head down position with shoulder brace can cause compression of 
brachial plexus and supraclavicular nerves and can lead to complications. Arms 
and elbows should be adequately padded and overextension of brachial plexus 
and ulnar nerve should be avoided. Lower extremity neuropathies and 
compartment syndromes have been reported after laparoscopy. The common 
peroneal nerve entrapment is more common in surgeries requiring lithotomy 
and can be prevented by padding the popliteal region. 
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ADVANTAGES AND DISADVANTAGES OF LAPAROSCOPY 
The advantages include the 
 Cosmetic results of small, non–muscle-splitting incisions and scars, 
 Decreased blood loss, 
 Less postoperative pain and ileus, 
 Shorter hospitalization and convalescence, and 
 Lower cost. 
 Less post operative complications. Wound complications such as 
infection and dehiscence and incisional hernia are less frequent, and host 
defence mechanisms may be greater in laparoscopic than in open surgery. 
The disadvantages include the 
 Laparoscopy is not suitable for patients with poor cardiac reserve and 
patients with severe respiratory disease, 
 Long learning curve for the surgeon (most complications occur during the 
first 10 laparoscopies), 
 The narrowed two-dimensional visual field on video,  
 The need for general anesthesia, and the often longer duration. 
 Ideally, surgeons should have more advanced laparoscopic skills, 
especially in knot tying, suturing, and working two instruments 
simultaneously. 
 CO2 pneumoperitoneum induced hemodynamic complications. 
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ALTERNATIVES TO CO2 PNEUMOPERITONEUM  
Newer techniques have been investigated to reduce the hemodynamic 
changes induced by CO2 pneumoperitoneum in laparoscopy. These include 
 Inert gases instead of carbon dioxide 
 Gasless laparoscopy 
INERT GASES  
Insufflation of inert gas like helium or argon instead of CO2 avoids the 
increase in PaCO2 and its consequences. 
(12) 
And hence hyperventilation is not 
required, but the ventilatory changes of the increased IAP persist. The 
hemodynamic changes produced by pneumoperitoneum using inert gas are 
similar to CO2 pneumoperitoneum. Unfortunately, the low blood solubility of 
the inert gases may increase the risk of gas embolism and this safety issue has to 
investigated. 
GASLESS LAPAROSCOPY  
Another alternative is gasless laparoscopy. The peritoneal cavity is 
expanded using abdominal wall lift obtained with a fan retractor. This technique 
avoids the hemodynamic and respiratory complications of increased IAP and 
also the consequences of the use of CO2. Renal and splanchnic perfusion is not 
altered. Port-site metastases after laparoscopic surgery for cancer are reduced 
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after gasless laparoscopy. This technique, therefore, is advantages for cardiac 
and pulmonary disease patients. However, gasless laparoscopy compromises 
surgical exposure and demands expertise. Combining abdominal wall lifting 
with low pressure CO2 pneumoperitoneum (5 mm Hg) may improve surgical 
conditions. 
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PHARMACOLOGY OF  
DEXMEDETOMIDINE 
 
HISTORY  
The α2-adrenergic agonists provide sedation, anxiolysis, hypnosis, 
analgesia, and sympatholysis. The initial use of α2 agonist in the anaesthesia are 
made by the observations of Clonidine. This was soon followed by a description 
of the minimum alveolar concentration (MAC) reduction of halothane by 
clonidine.
 Dexmedetomidine is a more selective α2 agonist than Clonidine. It 
has α2: α1  specificity of  1600 : 1 when compared to Clonidine which has 200:1.  
It was introduced in clinical practice in the United States in 1999 and approved 
by the FDA only as a short-term (<24 hours) sedative for mechanically 
ventilated adult ICU patients. Dexmedetomidine is now being used in operation 
theatres apart from ICU in various settings, including sedation and adjunct 
analgesia in the operating room, sedation in diagnostic and procedure units, and 
for other applications such as withdrawal/detoxification amelioration in adult 
and pediatric patients.
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PHYSICOCHEMICAL CHARACTERISTICS  
Dexmedetomidine is the d-enantiomer of medetomidine, a substance that 
has been used for sedation and analgesia in veterinary medicine for many years.
  
The chemical name is  (S)-4-[1-(2,3-dimethylphenyl)ethyl]-3H-imidazole . 
  Dexmedetomidine belongs to the imidazole subclass of α2 receptor 
agonists, similar to clonidine. It is freely soluble in water. 
 
METABOLISM AND PHARMACOKINETICS  
Dexmedetomidine has a rapid distribution half life and extensively 
metabolized in the liver and excreted in urine and feces. The major pathway of 
metabolism is conjugation (41%) followed by methylation (21%). 
Dexmedetomidine is 94% protein bound, and its concentration ratio between 
whole blood and plasma is 0.66. Dexmedetomidine has profound effects on 
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cardiovascular variables and may alter its own pharmacokinetics. With large 
doses, there is marked vasoconstriction, which probably reduces the drug's 
volumes of distribution. In essence, dexmedetomidine displays nonlinear 
pharmacokinetics. The elimination half-life of dexmedetomidine is 2 to 3 hours, 
with a context-sensitive half-time ranging from 4 minutes after a 10-minute 
infusion to 250 minutes after an 8-hour infusion. Postoperative patients sedated 
with dexmedetomidine display similar pharmacokinetics to the 
pharmacokinetics seen in volunteers. 
PHARMACOLOGY  
Dexmedetomidine is a nonselective α2 agonist. Alpha2 adrenoreceptors 
are membrane-spanning G proteins. Intracellular pathways include inhibition of 
adenylate cyclase and modulation of ion channels. There are three subtypes of 
α2 adrenoreceptors : α2A, α2B, and α2C. In humans the α2A receptors are primarily 
distributed in the periphery, and  α2B and α2C are present  in the brain and spinal 
cord. Postsynaptic located α2 adrenoreceptors in peripheral blood vessels 
produce vasoconstriction, whereas presynaptic α2 adrenoreceptors inhibit the 
release of norepinephrine, potentially attenuating the vasoconstriction. The 
overall response to α2 adrenoreceptors agonists is related to the stimulation of α2 
adrenoreceptors located in the CNS and spinal cord. These receptors are 
involved in the sympatholysis, sedation, and antinociception effects of α2 
adrenoreceptors. 
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EFFECTS ON THE CENTRAL NERVOUS SYSTEM  
SEDATION  
The sedative effect of the α2 agonists is due to the action on α2 receptors 
in the locus caeruleus and an analgesic effect is result of action at α2 receptors 
within the locus caeruleus and the spinal cord.
 (13) 
The quality of sedation 
produced by dexmedetomidine seems different compared with that produced by 
other sedatives acting through the GABA systems. Patients receiving 
dexmedetomidine infusions as part of their sedation regimen in the 
postoperative ICU setting have been described as being very easy to wake up 
and having the ability to follow commands and cooperate while being tracheally 
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intubated. Undisturbed, patients were noted to fall asleep right away. 
Dexmedetomidine causes less respiratory depression inspite causing good 
sedation providing a wide range of safety margin.  
 
The sedative effect is due to action of α2 agonists through the endogenous 
sleep-promoting pathways. Dexmedetomidine produces a decrease in activity of 
the projections of the locus caeruleus to the ventrolateral preoptic nucleus. This 
increases GABAergic and galanin release in the tuberomammillary nucleus, 
producing a decrease in histamine release in cortical and subcortical projections. 
The α2 agonists seem to inhibit ion conductance through L-type or P-type 
calcium channels and facilitate conductance through voltage-gated calcium-
activated potassium channels. The similarity between natural sleep (non–rapid 
eye movement) and dexmedetomidine-induced hypnosis has been speculated to 
maintain cognitive and immunologic function in the sleep-deprived states (as in 
the ICU). 
The α2 agonists have the advantage that their effects are readily reversible 
by α2-adrenergic antagonists (e.g., atipamezole). Atipamezole is not currently 
approved for human use. Similar to other adrenergic receptors, the α2 agonists 
also show tolerance after prolonged administration. Dexmedetomidine can be 
employed for addiction treatment; dexmedetomidine has been described for use 
in rapid opioid detoxification, cocaine withdrawal, and iatrogenic induced 
benzodiazepine and opioid tolerance after prolonged sedation. 
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ANALGESIA  
The analgesic effects of dexmedetomidine are complex. 
Dexmedetomidine do have an analgesic effect when injected via spinal or 
epidural.
 
Clonidine injected in the neural axis helps with short-term pain, cancer 
pain, and neuropathic pain.
 
 The effects on blood pressure are slower in onset 
with an epidural injection than with an intrathecal administration. Epidural 
effects are seen in 5 to 20 minutes. The primary site of analgesic action is 
thought to be the spinal cord.
 
Systemic use of dexmedetomidine shows narcotic 
sparing. There is 50% decrease in the narcotic requirement in ICU patients 
receiving dexmedetomidine for sedation in the post operative period.  
EFFECTS ON THE RESPIRATORY SYSTEM  
  Dexmedetomidine in sedative doses causes reduction of minute 
ventilation but the ventilator response to hypercarbia is well maintained. The 
changes in ventilation appeared similar to those observed during natural sleep. 
Ebert and colleagues,
(14) 
infusing dexmedetomidine to concentrations of 15 
ng/mL in spontaneously breathing volunteers, showed no change in arterial 
oxygenation or pH. At the highest concentrations, PaCO2 increased by 20%. 
Respiratory rate increased with increasing concentration from 14 breaths/min to 
25 breaths/min. When dexmedetomidine and propofol were titrated to equal 
sedative end points (BIS of 85), both resulted in no change in respiratory rate. In 
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a study comparing the effects of remifentanil and dexmedetomidine on 
respiratory parameters in normal volunteers,
 
the hypercapnic ventilatory 
response was unaffected even at doses that produced unresponsiveness to 
vigorous stimulation. PaCO2 increased mildly with dexmedetomidine, but it 
reached a plateau after the first increment. Dexmedetomidine also exhibited a 
hypercarbic arousal phenomenon, which has been described during normal 
sleep and is a safety feature.  
EFFECTS ON THE CARDIOVASCULAR SYSTEM  
The primary effects of α2 agonists on the cardiovascular system are 
reduction in heart rate, systemic vascular resistance; and thereby indirect 
reduction of myocardial contractility, cardiac output, and systemic blood 
pressure. By developing highly selective α agonists, it has been hoped to 
decrease some of these adverse cardiovascular effects and to maximize the 
desirable hypnotic-analgesic properties. The hemodynamic effects of a bolus 
dose of dexmedetomidine have shown a biphasic response. After an bolus IV 
injection of 2 µg/kg of dexmedetomidine, results in an initial increase in blood 
pressure (22%) and decrease in heart rate (27%) from baseline that occurred at 
within minutes after induction. The reason for this initial increase of blood 
pressure is due to the direct vasoconstrictive effect of dexmedetomidine on 
peripheral  α2 receptors. Heart rate returned to baseline by 15 minutes, and 
blood pressure gradually declined to approximately 15% below baseline by 1 
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hour. After an IM injection of the same dose, the initial increase in blood 
pressure was not seen, and heart rate and blood pressure remained within 10% 
of baseline. 
Ebert and colleagues
 (14)
 performed an elegant study in volunteers using a 
target-controlled infusion system to provide increasing concentrations (0.7 to 15 
ng/mL) of dexmedetomidine. The lowest two concentrations produced a 
decrease in MAP (13%) followed by progressive increase (12%). Increasing 
concentrations of dexmedetomidine also produce progressive decreases in heart 
rate (maximum 29%) and cardiac output (35%). Infusion of dexmedetomidine 
in volunteers also has been shown to result in a compensated reduction in 
systemic sympathetic tone without changes in baroreflex sensitivity. There is 
blunted response of heart rate and systemic sympathetic activation owing to 
sweating, but is less effective in blunting cardiac sympathetic response to 
shivering. 
The incidence of hypotension and bradycardia may be due to loading 
dose of the drug. This incidence of hypotension and bradycardia can be omitted 
or reduced by avoiding the bolus dose or not giving more than 0.5 µg/kg.  
Giving the loading dose over 20 minutes also decreases the incidence of 
transient hypertension. In several studies after IM and IV administration, 
dexmedetomidine caused, in a small percentage of patients, profound 
bradycardia (<40 beats/min) and occasionally sinus arrest/pause. Generally, 
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these episodes resolved spontaneously or were readily treated without adverse 
outcome by anticholinergics. It would be expected from its profile that 
dexmedetomidine would be beneficial to the ischemic myocardium. In animal 
models, dexmedetomidine showed some beneficial effects on the ischemic heart 
through decreased oxygen consumption and redistribution of coronary flow 
from nonischemic zones to ischemic zones after acute brief occlusion. 
Dexmedetomidine also decreases serum lactate in a dog model of coronary 
ischemia with an associated decrease in heart rate and measured 
catecholamines. It also produced an increase in the endocardial/epicardial blood 
flow ratio by 35%. 
The perioperative use of dexmedetomidine reduces the incidence of 
perioperative myocardial ischemia.
 
 More recently, Wallace and associates
 (15)
 
showed that the administration of clonidine in the preoperative period reduces 
the incidence of perioperative cardiac ischemia from 31% to 14%, and reduces 
the mortality for 2 years from 29% to 15% compared with placebo. The only 
data on potential benefits in perioperative ischemia prevention with 
dexmedetomidine are provided in an underpowered study in vascular surgery 
patients who received the drug in the perioperative period. Blood pressure and 
heart rate were lower in the dexmedetomidine group, but these patients also 
needed the use of more drugs intraoperatively to sustain blood pressure and 
heart rate. No reductions of ischemic events were noted. No rebound effects 
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have been found when discontinuing dexmedetomidine drips, even when it is 
given for more than 24 hours. 
A frequently reported side effect of dexmedetomidine has been a dry 
mouth. Dry mouth is due to a decrease in saliva production. 
USES  
Dexmedetomidine has been approved for ICU sedation in patients 
needing ventilation less than 24 hours. The well documented effects of 
anxiolysis, sedation, analgesia, and sympatholysis with minimal respiratory 
depression, makes it an ideal drug and it also has been used in various other 
clinical scenarios. 
INTENSIVE CARE UNIT  
Dexmedetomidine has advantages over propofol for sedation of 
postoperative patients receiving mechanical ventilation.  When both drugs were 
titrated to equal sedation as assessed by the BIS (approximately 50) and Ramsay 
sedation score (5), dexmedetomidine patients required significantly less 
narcotics (alfentanil 2.5 mg/hr versus 0.8 mg/hr). Heart rate was slower in the 
dexmedetomidine group, whereas MAP was similar. In the dexmedetomidine 
group the PaO2/FIO2 ratio was significantly higher. Time to extubation after 
discontinuation of the infusion was similar at 28 minutes. Patients receiving 
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dexmedetomidine seemed to have greater recall of their stay in the ICU, but all 
described this as pleasant overall. 
The decreased requirement for opioids (>50%) when dexmedetomidine is 
used for sedation compared with propofol or benzodiazepines has been 
confirmed by many studies. Most studies also describe more stable 
hemodynamics during weaning when dexmedetomidine is used for sedation. 
This is of obvious benefit in patients with high risk for myocardial ischemia. 
For sedation in the ICU, loading doses of 0.5 to 1 µg/kg have been used. 
Infusion rates of 0.1 to 1 µg/kg/hr are generally needed to maintain adequate 
sedation. Delirium in the ICU is a risk factor for increased length of stay and 
increased mortality.
 
 In a trial of sedation in ventilated patients with 
dexmedetomidine versus lorazepam, it was found that using dexmedetomidine 
infusions provided more days alive without delirium or coma and a greater 
amount of time spent at the appropriate sedation level compared with 
lorazepam. 
Clonidine have been used in the treatment of alcohol and drug 
withdrawal. In a comparison between clonidine and chlordiazepoxide in the 
treatment of patients with alcohol withdrawal, clonidine proved to give better 
anxiolysis with better hemodynamics.
 
 Dexmedetomidine has been successfully 
used in the treatment of -drug withdrawal. Maccioli 
(16)
 reported the successful 
use of dexmedetomidine in two adult patients, one with cocaine and alcohol 
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withdrawal symptoms, and another with withdrawal from prolonged use of 
benzodiazepines and narcotics in the ICU. Dexmedetomidine controlled 
withdrawal behavior and allowed for successful detoxification of young 
cardiothoracic patients (spanning the ages of days to 17 years) who developed 
drug withdrawal from prolonged use of benzodiazepines and narcotics in the 
ICU. Hence dexmedetomidine has been useful in narcotic, alcohol and 
benzodiazepine withdrawal. 
The unique characteristics of dexmedetomidine—providing adequate 
sedation with minimal respiratory depression—can be used when weaning 
patients from the ventilator. Siobal and colleagues
 (17)
 reported the successful 
weaning of five ventilated patients who had failed weaning secondary to 
agitation. Infusions of dexmedetomidine of 0.5 to 0.7 µg/kg/hr were used (no 
loading) and permitted the discontinuation of propofol in four of five patients. 
All patients were extubated while still on the dexmedetomidine infusion. One 
patient required reintubation for upper airway obstruction. The use of 
dexmedetomidine to facilitate daily ―wake up‖ tests in mechanically ventilated 
patients seems attractive, but few data have been published. 
The FDA approved the use of dexmedetomidine infusions for 24 hours or 
less. Multiple studies have shown the safety of using this drug for longer 
periods, however. In data collected from prescribing patterns in 10 institutions, 
it was shown that dexmedetomidine was used longer than 24 hours in 33.8% of 
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cases. It also was noted that 33% of patients received a loading dose, 27% of 
patients received a dose higher than the recommended maximum, and 60% of 
patients remained on the infusion after extubation. 
ANESTHESIA  
As a premedicant, dexmedetomidine, at IV doses of 0.5 µg/kg given 15 
minutes before surgery, seems efficacious, while minimizing the cardiovascular 
side effects of hypotension and bradycardia. Within this dosage range, 
dexmedetomidine reduces thiopental requirements (by ±30%) for short 
procedures,
(18)
 reduces the requirements of volatile anesthetics (by ±25%), and 
more effectively attenuates the hemodynamic response to endotracheal 
intubation compared with 2 µg/kg of fentanyl.
 
 Dexmedetomidine also has been 
evaluated as an IM injection (2.5 µg/kg) with or without fentanyl administered 
45 to 90 minutes before surgery. This regimen was compared with IM 
midazolam plus fentanyl and was found to provide equal anxiolysis, reduced 
response to intubation, smaller volatile anesthetic requirements, and a decreased 
incidence of postoperative shivering but a higher incidence of bradycardia. 
Atipamezole, a selective α2 antagonist, at 50 µg/kg was effective in reversing 
the sedation of dexmedetomidine (2 µg/kg intramuscularly), when used to 
provide sedation for brief operative procedures.
 
This reversal of effects resulted 
in a more rapid recovery than occurred after equisedative doses of midazolam. 
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Dexmedetomidine has been used for sedation for monitored anesthesia 
care. In a study comparing the efficacy of dexmedetomidine or propofol as a 
sedative agent in a group of 40 patients receiving local anesthesia or regional 
blocks, dexmedetomidine (1 µg/kg given over 10 minutes) when used for 
intraoperative sedation resulted in a slower onset than propofol (75 µg/kg/min 
for 10 minutes), but similar cardiorespiratory effects when titrated to equal 
sedation. The average infusion rate of dexmedetomidine intraoperatively to 
maintain a BIS value of 70 to 80 was 0.7µg/kg/min. Sedation was more 
prolonged after termination of the infusion, as was recovery of blood pressure. 
Smaller doses of opioid were needed in the first hour, however.
 
 
Dexmedetomidine sedation has been done successfully in pediatric 
patients. Two studies, comprising 140 children 1 to 7 years old, reported 
successful sedation for MRI scans compared with midazolam or propofol.
 
 
When dexmedetomidine is used as a premedication before general 
surgery for cataract removal, intraocular pressure is decreased (33%), stress 
hormone  secretion is reduced, perioperative narcotic requirements are less, and 
recovery is more rapid.
 
 
For maintenance of anesthesia, dexmedetomidine has been used in 
patients undergoing multiple types of surgery. In patients given an infusion 
regimen to achieve a plasma concentration of slightly less than 1 ng/mL, 
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combined with 70% nitrous oxide, dexmedetomidine reduced isoflurane 
requirements by 90% compared with a control group. One retrospective study 
and two prospective, randomized controlled trials in bariatric surgical patients 
have found that a balanced anesthetic with desflurane or propofol plus 
dexmedetomidine (0.5 to 0.8µg/kg bolus plus 0.4 µg/kg/hr infusion) reduces 
postoperative pain scores and morphine consumption, and improves 
hemodynamics compared with desflurane-fentanyl or propofol-fentanyl 
anesthetics.
 
 
In patients presenting for vascular surgery, three infusion rates of 
dexmedetomidine were compared with a placebo infusion starting 1 hour before 
surgery and administered until 48 hours after surgery. In the groups receiving 
dexmedetomidine, more vasoactive agents were required to maintain 
hemodynamics intraoperatively, but less tachycardia was noted postoperatively. 
No other significant differences were noted between the groups. 
Grant and colleagues
(19)
 described the use of dexmedetomidine when 
securing the airway with a fiberoptic intubation in three patients undergoing 
cervical spine surgery. The procedure was well tolerated with no hemodynamic 
compromise or respiratory depression. Because this drug provides good 
sedation with maintainence of respiration, it has been used in patients 
undergoing awake craniotomies with functional testing and 
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electrocorticography or awake carotid endarterectomies with fewer fluctuations 
from the desired sedation level and more stable hemodynamics. 
Another use of dexmedetomidine has been as an anesthetic adjunct or 
sedative agent for patients who are susceptible to narcotic-induced respiratory 
depression or sleep apnea. This is evident in the use of dexmedetomidine in 
bariatric surgery. 
 
The addition of dexmedetomidine infusions to assist on 
transesophageal echocardiography examination has been described, with better 
hemodynamic profile and improved patient satisfaction than with 
benzodiazepine and narcotics alone, with no added respiratory depression. 
The use of dexmedetomidine has dramatically increased. This highly 
selective α2 agonist has a set of unique effects that include titratable sedation, 
sympatholysis, and analgesia without significant respiratory depression. 
Originally approved as a sedative in the ICU, it has found many off-label 
applications in the ICU, the operating room, and perioperative environment. 
The off-label use of dexmedetomidine in infants and children is rapidly 
increasing. More than 800 reports have been published regarding its use in this 
population. 
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VARIOUS ANAESTHETIC TECHNIQUES 
FOR LAPAROSCOPIC SURGERY 
 
PREOPERATIVE EVALUATION OF THE PATIENT  
Without regard to surgical contraindications, absolute contraindications to 
laparoscopy and CO2 pneumoperitoneum are rare, and some still require 
characterization. Pneumoperitoneum is contraindicated in patients with 
increased intracranial pressure (e.g., tumor, hydrocephalus, head trauma) and 
hypovolemia. Laparoscopy can be performed safely in patients with ventricular 
peritoneal shunt and peritoneojugular shunt that are provided with 
unidirectional valve resistant to IAPs used during CO2 pneumoperitoneum.  
Cardiac patients coming for laparoscopic surgery, cardiac function should 
be evaluated because of the hemodynamic changes caused by 
pneumoperitoneum and patient position can aggravate the present medical 
situation, particularly in a compromised ventricular function. Patients with 
severe congestive heart failure and advanced valvular conditions are at 
increased risk to develop cardiac complications during laparoscopy than 
patients with ischemic cardiac disease. The choice of laparoscopy verses 
laparotomy in these patients must be made taking in account, the postoperative 
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benefits of laparoscopy against the intraoperative risks of laparoscopy. Gasless 
laparoscopy may represent an alternative for these patients. Because of the side 
effects of increased IAP on renal function, patients with renal failure deserve 
special care to optimize hemodynamics during pneumoperitoneum, and the 
concomitant use of nephrotoxic drugs should be avoided. 
In patients with respiratory disease, even though laparoscopy appears 
superior to laparotomy because of reduced postoperative respiratory dysfunction 
but in laparoscopy there is increased risk of pneumoperitoneum and risk of 
ventilation perfusion mismatching. DVT prophylaxis is the same for 
laparoscopy and laparotomy. 
PREMEDICATION 
Premedication should be adapted based on the duration of the 
laparoscopy and to the necessity for quick recovery in daycare setting. All 
patients undergoing laparoscopy should receive antacid prophylaxis and an anti 
emetic preoperatively. Preoperative administration of IV paracetemol may be 
helpful in reducing postoperative pain and opiate requirements.  
PATIENT POSITIONING AND MONITORING 
Patients must be positioned with great care to prevent nerve injuries; 
padding should protect from nerve compression at pressure points. The head up 
or head low position should be done slowly and gradually as sudden change in 
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position may cause drastic changes in cardiovascular and respiratory system. 
The patient tilt should be restricted to 15 to 20 degrees. After intubation and 
postioning the patient, the position of endotracheal tube as to be checked since 
change in position may cause the tube to move in or move out resulting in 
accidental endobronchial or extubation respectively. Induction and release of 
the pneumoperitoneum should be smooth and progressive. Mask ventilation 
should be as gentle as possible without inflating the stomach, if inflated also 
ryles tube should be placed and stomach decompressed before trocar placement 
to avoid gastric perforation specifically in upper abdominal laparoscopy 
procedures. Emptying of the bladder before all laparoscopic surgeries is must. 
RECOMMENDED MANDATORY MONITORING 
 Electrocardiography 
 Non invasive blood pressure 
 Pulse oximetry 
 Capnometry and EtCO2 
 Temperature 
 Invasive monitors like intra arterial blood pressure, central venous 
pressure, transesophageal echocardiography will be more helpful in case 
of patients with severe cardiac disease. 
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ANESTHETIC TECHNIQUES  
1. General anaesthesia, 
2. Local anaesthesia, and 
3. Regional anesthesia  
All the three have all been used successfully and safely for laparoscopy. 
1. General Anesthesia 
General anesthesia with endotracheal intubation and controlled ventilation is 
certainly the safest and most commonly used technique and therefore is 
recommended in all patients and for long laparoscopic procedures.  
 Choice of induction drugs does not have any role. Either of the induction 
drugs can be used, propofol, thiopentone or ethiomdate can be used. 
Profolol induction seems to be associated with lower incidence of post 
operative complications. 
 Although N2O is not contraindicated in laparoscopic procedures omission 
of its use seems to cause decreased bowel distention and improve the 
surgical  conditions for intestinal and colonic surgery. 
 Adequate analgesia with fentanyl or remifentanyl is required. 
 During CO2 pneumoperitoneum, minute ventilation must be adjusted to 
maintain PETCO2 between 30 and 35 mm Hg by adjusting the respiratory 
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rate rather than tidal volume and this may helpful in COPD patients by 
preventing barotraumas. 
 IAP should be monitored, and kept ideally between 12-15 mm of Hg to 
reduce hemodynamic and respiratory changes. 
 Adequate fluid management minimizes hemodynamic alterations. 
 Muscle relaxation should be adequate especially during trocar placement. 
 Infusion of vasodilating drugs, such as nitroglycerine, α2-adrenergic 
receptor agonists such as Clonidine,
 
and remifentanil
 
reduces the 
hemodynamic alterations of CO2 pneumoperitoneum and may facilitate 
management of cardiac patients. 
 Choice of inhalational agents – newer inhalational agents like 
sevoflurane, isoflurane or desflurane can be safely used. 
 All patients should be reversed after adequate breathing attempts with 
neostigmine and glycopyrrolate and after adequate recovery patient 
should be shifted with PACU. 
The laryngeal mask airway may be an instead of endotracheal intubation 
even though it does not rule out the risk of gastric aspiration.
 
It allows 
controlled ventilation and accurate monitoring of PETCO2. Since 
pneumoperitoneum decreases the pulmonary compliance it frequently results in 
higher airway pressures exceeding  20 cm H2O only ProSeal laryngeal mask 
airway which seal upto 30 cm of H2O can be used in laparoscopy. 
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Short procedures using low intra abdominal pressure can be done with 
general anesthesia in patients breathing spontaneously without intubation. It has 
an advantages over endotracheal intubation that avoids tracheal irritation and 
use of muscle relaxant. But it is not ideally recommended and its better to use 
an laryngeal mask airway in these type of patient for short procedures. 
2. Local and Regional Anesthesia  
It is ideally used for short procedures at day care set up. The advantages 
of local anaesthesia over general anaesthesia include fast and better recovery, 
decreased post operative nausea and vomiting, early diagnosis of complications, 
and fewer hemodynamic changes. Laparoscopic surgeries done under local 
anaesthesia needs precise and gentle surgical technique and since it is always 
associated with increased patient anxiety, pain, and discomfort during the 
surgical manipulation of organs, local anesthesia is always supplemented with 
intravenous sedation.  
Regional anesthesia, both epidural and spinal techniques, combined with 
the trendelenburg position can be used for gynecologic laparoscopy without 
major hemodynamic or ventilatory impairment. Laparoscopic cholecystectomy 
has been successfully performed using epidural anesthesia in COPD patients.
 
 
The anaesthetic stress of general anaesthesia  is reduced by regional anesthesia. 
Both epidural and local anesthesia have the same benefits and disadvantages.  
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The advantages of regional anaesthesia include decreased requirement of 
sedatives, better muscle relaxation than general anaesthesia.  The disadvantages 
being it does not alleviate the discomfort due to abdominal distension and 
shoulder tip pain due diaphragmatic irritation, and chances are there that the 
level of block may rise due to increased intra abdominal pressure. Extensive 
sensory block (T4-L5) is usually necessary for surgical laparoscopy and may 
also lead to discomfort. The epidural administration of opiates or clonidine, or 
dexmedetomidine, may help to provide adequate analgesia and decreased 
hemodynamic response to CO2 pneumoperitoneum. In case of gaseless 
laparoscopy regional anaesthesia can provide adequate analgesia. 
POSTOPERATIVE MONITORING  
Hemodynamic monitoring should be continued in the PACU. The 
increased systemic vascular resistance, usually last for longer duration even 
after the release of pneumoperitoneum. After the release of pneumoperitoneum 
there exists a hyper dynamic circulation due to stagnating blood entering into 
the central circulation from peripheries, this could lead to adverse events in 
patients with cardiac disease. 
Even though there is decreased pulmonary complications in laparoscopy 
than laparotomy, PaO2 still decreases after laparoscopic cholecystectomy. There 
is an increased oxygen demand in all post laparoscopy patients so it is always 
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recommended to give supplemental oxygen, even to healthy patients. All 
patients should be given anti emetic to prevent post operative nausea and 
vomiting and should be provided adequate analgesia. 
PRACTICE GUIDELINES 
European Association of Endoscopic Surgery has given guidelines on 
Pneumoperitoneum for Laparoscopic Surgery. 
They have given the monitoring guidelines for normal patients and high risk 
patients undergoing laparoscopic surgeries. 
ASA I/II patients 
Pneumoperitoneum of intra abdominal pressure of 12 – 15 mm of Hg rarely 
causes adverse hemodynamic effects (grade A). 
All the basic monitoring are recommended including end tidal CO2 (grade A). 
ASA III/IV 
It is advised in all high risk patients to go for alternative of gaseless laparoscopy 
(grade B) 
Even if pneumoperitoneum is indicated IAP should be as low as possible to 
reduce perfusion changes in renal, hepatic and other organs (grade B). 
In all high risk cases, thromboprophylaxis is mandatory (grade A). 
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Sequential intermittent pneumatic compression of lower extremities is 
recommended for all prolonged laparoscopic procedures (grade A/B). 
In cardiac patients, 
 Invasive monitoring is always indicated. Invasive blood pressure and 
central venous pressure monitoring (grade A) 
 Adequate pre-op volume loading +/- B-blockers is recommended     
(grade A) 
In patients with poor respiratory reserve, 
 Laparoscopic surgery definitely has better outcome than open method 
(grade A) 
 Intra- and post-op ABG monitoring recommended (grade A) 
 Maintaining minute ventilation  reduce respiratory acidosis (grade A) 
 
Grade A – strongly recommended and studies have proved it 
Grade B – it is advisable and definitely have positive outcome on the patients. 
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REVIEW OF LITERATURE 
STUDIES RELATED TO CO
2
 PNEUMOPERITONEAL 
RESPONSE IN LAPRAROSCOPY 
1. Jean L.Moris et al published in American College of cardiology, 1998, 
the hemodynamic changes induced by laparoscopy and its endocrine 
correlates and effects of Clonidine on CO2 pneumoperitoneum. The study 
conclusion was vasopressin and catecholamines probably mediated the 
increase in systemic vascular resistance observed during 
pueumoperitoneum. Clonidine given before pneumoperitoneum reduces 
the catecholamine release and attenuates hemodynamic changes during 
laparoscopy.
(26)
 
2. D.Jee et al, published in British Journal of Anaesthesia 2009, the effect of 
intravenous magnesium sulphate attenuates arterial pressure increase 
during laproscopic cholcystectomy. They concluded that intravenous 
magnesium sulphate 50 mg/kg given before pneumoperitoneum  
attenuated the arterial pressure  increase due to pneumperitoneum. This 
attenuation apparently related to reduction in release of  catecholamines 
and vasopressin or both.
(27)
 
3. K. Myre et al in Acta Anaesthesiologica Scandinavia, march 2003 have 
studied the effect of high dose remifentanyl(0.39 μg/kg/min) infusion in 
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attenuating the stress response to pneumoperitoneum in 18 patients 
undergoing laproscopic fundoplication . The study showed  that high dose 
remifentanyl depressed epinephrine release to pneumoperitoneum.
(28)
 
4. Jens fromholt Larsen et al, in Journal of Gasteroenterolgy surgery 2002, 
studied the effect of stress response of gasless and carbondioxide 
pneumoperitoneum. The study showed carbondioxide pneumoperitoneum 
induced significant change in stress hormones.
(29)
 
5. Gopta.k et al in Saudi Journal of Amaesthesiology 2011, have studied the 
effect of oral pregabalin (150mg) and oral Clonidine (200μg) for 
hemodynamic stability during laryngoscpy and laproscopic 
cholecystectomy and said that both drugs causes anxiolysis and sedation 
with hemodynamic stability.
(30)
 
6. Tripathi DC et al, in Journal of Anaesthesiology clinical pharmacology 
October 2011, have studied two different doses of intravenous Clonidine    
(1μg/kg and 2μg/kg) in attenuating hemodynamic stress response during 
laparoscopic cholecystectomy. The study concluded that Clonidine 
2μg/kg intravenously given 30 minutes before induction is safe and 
effective preventing hemodynamic stress response during laparoscopy.
(31
 
7. Maharajan SK in Kattmandu University Medical Journal 2005, studied 
the effect of propanalol in decreasing stress response in laparoscopic 
cholecystectomy and concluded that propanolol (1 mg intravenous) 
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effectively blunts the stress response to CO2 pneumoperitoneum during 
laparoscopic cholecystectomy.
(32)
 
STUDIES RELATED TO DEXMEDETOMIDINE FOR STRESS 
ATTENUATION 
1. Poonam S.Ghodki et al  in journal of Anaesthesiology clinical 
pharmacology 2012, studied dexmedetomidine as an anaesthetic adjuvant 
in laproscopic surgery and they concluded dexmedetomidine ia an 
effective adjunct without the fear of awareness under anaesthesia and 
resulted in 62.5% reduction in induction dose of propofol and 30% less 
end tidal isoflurane required. 
(20)
 
2. Pekka Talke et al, Department of Anaesthesia, University of California 
published a paper in Anaesthesia and Analgesia on hemodynamic and 
adrenergic effects of perioperative effects of dexmedetomidine after 
vascular surgery. The study showed the group of patients receiving 
dexmedetomidine infusion had decrease heart rate and plasma nor 
adrenaline values during emergence from anaesthesia.
(21)
 
3. M. Aho et al in Anaesthesia and Analgesia published an article that 
intramuscularly given dexmedetomidine of 2.4 μ/kg 45 minutes before 
surgery attenuated hemodynamic and stress response to gynecologic 
laparoscopy. 
(22)
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4. H.A.Mowafi et al in British Journal of Anaesthesia, 2008, published the 
effect of dexmedetomidine premedication on intra ocular pressure 
changes after scoline and intubation. They showed that dexmedtomidine 
0.6μ/kg intravenous resulted in decrease in intraocular and mean 
arteriolar pressure in the study group. They concluded dexmedetomidine 
could be a beneficial adjunct in open globe injuries.
(23)
 
5. Ahmed M Muktar et al, Department of medicine, Cairo University 
studied the use of dexmedetomidine in paediatric cardiac surgery. They 
concluded dexmedetomidine attenuated increase in heart rate , blood 
pressure, cortisol and catecholamine concentration in paediatric patients 
undergoing open heart surgeries.
(24)
 
6. Fredi  Menda et al, Department of Anaesthesia, yeditepe university, 
Turkey, published in annals of cardiac Anaesthesia, about the effect of 
using dexmedetomidine as an adjunct to attenuate hemodynamic response 
to endotracheal intubation in patients undergoing Fast trach CABG. The 
study concluded dexmedetomidine can be safely used to attenuate the 
hemodynamic response to endotracheal intubation in patients undergoing 
myocardial revescularisation receiving β blockers.(25) 
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AIM OF THE STUDY 
 
To study the effect of dexmedetomidine in attenuating the arterial pressure 
increase due to CO2 pneumoperitoneum in patients posted for elective 
laparoscopic cholecystectomy 
 
 
 
 
 
 
 
 
 
 
55 
 
MATERIALS & METHODS 
STUDY DESIGN 
It is single blinded randomized study done at Kilpauk Medical 
College/Government Royapettah Hospital. 
PATIENT SELECTION: 
40 patients of ASA 1 & 2 of both sex undergoing elective laparoscopic 
cholecystectomy are selected. 
GROUP: 
Group A: 20 patients receiving normal saline IV infusion 10 minutes before 
pneumoperitoneum                                                                                    
Group   B: 20 patients receiving IV dexmedetomidine (0.5μ/kg IV bolus 
followed by IV infusion of 0.5 μ /kg/hr) 10 minutes before pneumoperitoneum 
INCLUSION CRITERA 
 ASA 1 &2     
 18  to 60 years        
 Both sex         
 Elective cholecystectomy       
 Without any co morbid condition      
 Undergoing general anaesthesia 
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EXCLUSION CRITERIA: 
 Patient on any drug treatment which may interfere with   
dexmedetomidine  
 Hypertension        
 Diabetes mellitus          
 Cardiovascular & kidney disease              
 Acute cholecystectomy                      
 Endocrine or metabolic diseases  
 Autonomic neuropathy 
 Patients on chronic β blocker therapy       
MONITORING: 
 Pulse oximetry         
 NIBP          
 ECG          
 Et CO2  
 Airway pressure monitoring (PIP and mean pressure) 
 Intra abdominal pressure (maintained around 12 mm of Hg) 
 Urine output monitoring  
 Temperature monitoring    
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CONDUCT OF STUDY; 
After ascertaining the inclusion criteria preoperative investigations were 
recorded which included complete hemogram, blood sugar, urea, creatinine, 
serum electrolytes, blood grouping, blood coagulation tests, urine routine, chest 
X-ray and ECG. 
Preoperative instructions: 
 All patients are explained about the study and written informed consent 
obtained. 
 Patients are advised a 6 hour period of absolute fasting. 
 All patients receive an antacid prophylaxis of injection ranitidine 50 mg 
IV and injection ondansetron 8 mg IV on the morning of surgery. 
 All the patients are premedicated with injection glycopyrrolate 0.2 mg IM 
one hour before surgery. 
 40 patients are randomized into two groups (group A and group B). 
Conduct of anaesthesia: 
 After shifting the patients to operation theatre patients are connected to 
ECG,   pulse oximetry, and NIBP monitors. 
 All patients are started with ringer lactate at 75 ml/hr. 
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 All patient given fentanyl 2μg/kg IV and pre oxygenated with 100% 
oxygen for 3 – 5 minutes. 
 In all the patients, trachea was intubated after induction of anaesthesia 
with propofol 1.5-2 mg/kg and vecuronium 0.1 mg/kg. 
 Anaesthesia maintained with 1.5-2% sevoflurane and 4:2 N2O/O2 at 6 
litres/ minute. 
 After induction of general anaesthesia and 10 minutes before creation of 
CO2 pneumoperitoneum study group (group B) received IV 
dexmedetomidine   0.5μg/kg bolus dose over 10 minutes followed by 
0.5μ/kg/min infusion and control group (group A)  received  normal saline 
at same infusion rate. In both the groups infusion was continued till 
dissection of gall bladder was complete. 
 Arterial pressure and heart rate are measured before induction, pre 
pneumoperitoneum, at pneumoperitoneum(P0), at 5 min , 10 min, 20 min, 
30 min after pneumoperitoneum and post surgery. 
 Serum noradrenaline samples are taken pre pneumperitoneum and 
at 10 minute pneumoperitoneum. 
 After completion of surgery, pneumoperitoneum deflated slowly and after 
the patient had adequate respiratory attempts patient reversed with 
glycopyrrolate and neostigmine IV. 
 Adequate oral suctioning done and the patients are extubated. 
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 After adequate recovery from general anaesthesia, patients were shifted to 
recovery room where they remained and observed until there was 
complete recovery from general anaesthesia for 2 hours. 
Noradrenaline  assay 
 Serum samples are taken in both plain tube and EDTA tubes and 
immediately transferred to the laboratory. 
 Assay done with ECLIA using Elecsys 2010 system  
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DEFINITION OF VARIABLES:  
 Preoperative values of pulse rate, systolic, diastolic and mean blood 
pressures were recorded read as outside theatre. 
 Patients were preoxygenated and the reading of pulse rate, systolic, 
diastolic and mean blood pressures were recorded and was read as 
preoperative.  
 Patients were intubated and the reading of pulse rate, systolic, diastolic 
and mean blood pressures were recorded and was read as 
prepneumoperitoneum. 
 After induction of pneumoperitoneum (intra abdominal pressure reaching 
12    mm of Hg) reading of  pulse rate, systolic, diastolic and mean blood 
pressures were recorded and was read as P0. 
 From the induction of pneumoperitoneum, pulse rate, systolic, diastolic 
and mean blood pressures were recorded at 5
th
 minute and was read as P5. 
 From the induction of pneumoperitoneum, pulse rate, systolic, diastolic 
and mean blood pressures were recorded at 10
th
  minute and was read as 
P10. 
 From the induction of pneumoperitoneum, pulse rate, systolic, diastolic 
and mean blood pressures were recorded at  20
th
  minute and was read as 
P20. 
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 From the induction of pneumoperitoneum, pulse rate, systolic, diastolic 
and mean blood pressures were recorded at  30
th
  minute and was read as 
P30. 
 After completion of the surgery patient extubated  and pulse rate, systolic, 
diastolic and mean blood pressures were recorded and was read as post 
surgery . 
STATISTICAL ANALYSIS:  
 It‘s a randomized controlled clinical study 
 Variables were analysed with Student‗t‘ test 
 Variables like age, sex, weight, height were compared using Levene‘s  
test for equality of variance 
 Sample size obtained according to previous background study  
 ‗p‘ value less than 0.05 was taken as significant 
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OBSERVATION & RESULTS 
 
In this study a total of 40 patients were studied in which 20 patients in the 
control (group A) and 20 in the study group (group B). The demographic 
parameters like age distribution, weight of the patient(kg), height of  the patient 
(cm), and other parameters like duration of anaesthesia, duration of surgery, 
preoperative pulse rate, systolic, diastolic and mean arterial pressure were 
compared between the two groups(group A & group B) and there was no 
statistical difference between the  two groups( p ˃ 0.05). 
 
 
 
 
 
 
 
 
63 
 
DEMOGRAPHIC AND OTHER PARAMETERS 
 
 
VARIABLE CONTROL 
(GROUP A) 
STUDY  
(GROUP B) 
P VALUE 
AGE    48.2 ±5 49.1±4 0.607 
SEX  M/F 8/12 9/11 0.704 
WEIGHT (kg) 77.8±8 70.2±6 0.329 
HEIGHT (cm) 163.7±7 165±7 0.509 
DURATION OF 
SURGERY 
39.3±4 39.9±4 0.620 
DURATION OF 
ANAESTHESIA 
67.5±6 69.2±4 0.340 
PREOP  
PULSE RATE 
87.8±10 86.2±4 0.510 
PREOP 
SYSTOLIC BP 
107.2±11 102.9±18 0.420 
PREOP 
DIASTOLIC BP 
63.6±8 67.3±9 0.205 
PREOP 
 MEAN BP 
78.1±9 81.9±9 0.220 
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Chart-1 Age distribution between two groups 
 
 
                             
Chart-2 Sex distribution in both groups 
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Chart-3 Height (in cms) between both groups 
 
 
Chart-4 Weight (in kg) between both groups 
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Chart-5 Duration of surgery and duration of anaesthesia are comparable 
between two groups. 
 
Chart-6  Preoperative pulse rate, systolic, diastolic and mean blood pressure  
are comparable between two groups. 
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PULSE RATE 
VARIABLE CONTROL 
(GROUP A) 
STUDY 
(GROUP B) 
P VALUE 
MEAN P 0 89.2 77.4 0.000 
MEAN P5 85.4 75.0 0.000 
MEAN P 10 87.0 73.8 0.000 
MEAN P 20 88.0 72.1 0.000 
MEAN  P 30 84.4 75.2 0.003 
MEAN  POST 
SURGERY 88.5 79.6 
 
0.003 
 
P value <0.05 - significant 
Test method – student t test 
The pulse rate is significantly low in the study group (group B) than the control 
group (group A) during the period of pneumoperitoneum at 0 min (77 VS 89), 
5
th
 min (75 vs 85), 10
th
  min(73 vs 87), 20
th
 min (88 vs72) and 30
th
 min (75 vs 
84) and also post surgery  (79 vs 88). (chart -7) 
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Chart-7 Bar diagram shows heart rate is significantly lower (p value < 0.05) in 
study group than the control group at all point of time. 
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SYSTOLIC BLOOD PRESSURE 
VARIABLE CONTROL 
(GROUP A) 
STUDY  
(GROUP B) 
P VALUE 
SYSYTOLIC P 0 109.2 103.8 0.003 
SYSTOLIC P5 119.3 108.5 0.000 
SYSTOLIC P 10 128.3 110.8 0.000 
SYSTOLIC P 20 123.9 115.4 0.000 
SYSTOLIC P 30 128.5 120.9 0.000 
SYSTOLIC 
POST SURGERY 130.5 123.7 
 
0.001 
 
P value <0.05 - significant 
Test method – student t test 
The systolic blood pressure is significantly low in the study group (group 
B) than the control group (group A) during the period of pneumoperitoneum  at 
0 min (103 vs 109),      5
th
 min (108 vs 119), 10
th
  min(110 vs 128), 20
th
 min 
(115 vs 123) and 30
th
 min (120 vs 128) and also post surgery(123 vs 130). 
(chart- 8) 
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Chart-8 Bar diagram shows systolic blood pressure is significantly lower        
(p value < 0.05) in study group than the control group at all point of time. 
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DIASTOLIC BLOOD PRESSURE 
VARIABLE CONTROL 
(GROUP A) 
STUDY  
(GROUP B) 
P VALUE 
DIASTOLIC P 0 80.3 75.0 0.000 
DIASTOLIC P5 84.2 76.2 0.000 
DIASTOLIC P 10 91.3 76.9 0.000 
DIASTOLIC P 20 89.8 81.2 0.000 
DIASTOLIC P 30 86.9 80.1 0.003 
DIASTOLIC 
POST SURGERY 82.8 74.7 
 
0.001 
 
P value <0.05 - significant 
Test method – student t test 
The diastolic blood pressure is significantly low in the study group (group 
B) than the control group (group A) during the period of pneumoperitoneum  at 
0 min (75 vs 80), 5
th
 min (76 vs 84), 10
th
  min(76 vs 91), 20
th
 min (81 vs 86) and 
30
th
 min (80 vs 86) and also post surgery(74 vs 82). (chart-9) 
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Chart-9 Bar diagram shows diastolic blood pressure is significantly lower       
(p value < 0.05) in study group than the control group at all point of time. 
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MEAN  BLOOD PRESSURE 
VARIABLE CONTROL 
(GROUP A) 
STUDY 
(GROUP B) 
P VALUE 
MEAN P 0 92.9 85.7 0.000 
MEAN P5 98.5 87.5 0.000 
MEAN P 10 104.9 89.3 0.000 
MEAN P 20 102.8 94.3 0.000 
MEAN  P 30 99.0 94.5 0.003 
MEAN  POST 
SURGERY 94.7 84.7 
 
0.001 
 
P value <0.05 - significant 
Test method – student t test 
The mean blood pressure is significantly low in the study group (group B) 
than the control group (group A) during the period of pneumoperitoneum  at 0 
min (85 VS 92), 5
th
 min (87 VS 98), 10
th
  min(89 VS 104), 20
th
 min (94 VS 
102) and 30
th
 min (94 VS 99) and also post surgery(84 VS 94). (chart-10) 
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Chart-10 Bar diagram shows mean arterial pressure is significantly lower        
(p value < 0.05) in study group than the control group at all point of time. 
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SERUM NORADRENALINE VALUES 
 
VARIABLE CONTROL 
(GROUP A) 
STUDY  
(GROUP B) 
P VALUE 
PRE PNEUMO 
PERITONEUM 
200.5 194.8 0.367 
10 MIN PNEUMO 
PERITONEUM 
481.0 302.3 0.000 
 
P value <0.05 significant 
The nor adrenaline values are not significant between the control group 
(group A) and the study group (group B) before pneumoperitoneum (200.5 vs 
194.8 pg/ml). 
But the values between the control group (group A) and the study group 
(group B) taken at 10 minute pneumoperitoneum are very much significant 
(481.0 vs 302.3 pg/ml) suggesting attenuation of hemodynamic response arising 
due to CO2 pneumoperitoneum.  (chart -11) 
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Chart-11 Bar diagram shows that noradrenaline  levels are higher in the control 
group after induction of  pneumoperitoneum but there is significant lower levels 
in the study group after induction of pneumoperitoneum. 
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DISCUSSION 
In this study, neurohormonal hemodynamic response of 
dexmedetomidine in attenuating the arterial pressure increase is studied. The 
results obtained showed an effective attenuation of blood pressure and heart rate 
in patients who received dexmedetomidine as compared to the patients who 
received normal saline. The study also showed that dexmedetomidine 
effectively suppressed the noradrenaline release due to pneumoperitoneum in 
the patients who received dexmedetomidine but not in patients who received 
normal saline. Thus proving that dexmedetomidine acts by suppressing the 
central sympathetic outflow (sympatholytic) there by suppressing the 
hemodynamic changes induced by the CO2 pneumoperitoneum. 
Many studies have been done on laparoscopic surgery and highlighted 
hemodynamic changes during pneumoperitoneum and also proved by endocrine 
co relates the reason for the pneumoperitoneal response. The landmark study 
which was conducted about the hemodynamic response of laparoscopy with 
CO2 pneumoperitoneum by Jean L. Loris et al which was published in JACC 
1998,
(26)
 showed that there is significant reduction of cardiac output and 
increase in mean arterial pressure and systemic vascular resistance.  In the 
present study we also observed that systolic, diastolic and mean arterial pressure 
increased abruptly after induction of pneumoperitoneum  and this response 
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sustained during the entire pneumoperitoneum period in the control group 
(group A) as observed by the previous studies.  
Dexmedetomidine being a anxiolytic, sedative and sympatholytic  
effectively suppresses the stress response in various situations. In the study by 
Poonam S.Ghodki et al in journal of Anaesthesiology clinical pharmacology 
2012,
(20)
studied dexmedetomidine as an anaesthetic adjuvant in laparoscopic 
surgery and they concluded dexmedetomidine is an effective adjunct without 
the fear of awareness under anaesthesia and resulted in 62.5% reduction in 
induction dose of propofol and 30% less end tidal isoflurane required.  Similarly 
Clonidine which is congener of dexmedetomidine has been studied in 
attenuating the stress response in laparoscopic surgeries.   
In the study by Jean L. Loris et al
(26)
  that found that  Clonidine 
effectively attenuated the stress response due to  pneumoperitoneum. Similarly 
in our study we found that in the dexmedetomidine group (group B) 
hemodynamic responses to the induction of pneumoperitoneum were effectively 
blunted and the heart rate and blood pressure levels when compared to the 
control group (group A). Even though study conducted by D.Jee et al, published 
in British Journal of Anaesthesia 2009,
 (27)
  studied the effect of magnesium 
sulphate on pneumoperitoneum response showed that there is no change in heart 
rate in the magnesium group when compare to control group. But Jean L,Loris 
showed that Clonidine significantly reduced both heart rate and blood pressure.  
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Our study reports also show the same that dexmedetomidine attenuates both 
heart rate and blood pressure significantly. 
ENDOCRINE CORRELATES OF LAPAROSCOPY 
Loris et al
(26)
 in his study showed the endocrine correlation of 
pneumoperitoneal response. The study showed that the reason the increase in 
the peripheral vascular response is due to increase in vasopressin and 
catecholamines  levels. More precisely the study showed that vasopressin levels 
correlated closely with changes in peripheral vascular response.  Induction of 
pneumoperitoneum causes rapid and marked release of vasopressin and it well 
co related with changes in intra abdominal pressure, intrathoracic and right 
atrial pressure. The reason for release of vasopressin is not clearly known and it 
may be probably due to mechanical stimulation of peritoneal receptors. 
Catecholamines particularly noradrenaline which was released during 
pneumoperitoneum also contributes to increase in peripheral vascular 
resistance. The stimulus for the release of noradrenaline is not known. The 
reason may be due to surgical stress induced by the pneumooeritoneum in 
laparoscopy.  
Loris et al also studied the effect of Clonidine on laparoscopy and showed 
that Clonidine effectively attenuated the release of catecholamines and thereby 
decreasing the afterload. But study didn‘t showed correlation with vasopressin. 
Vasopressin and cortisol levels were same in both the groups. Since 
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dexmedetomidine has similar mode of action as Clonidine we assumed that 
vasopressin levels do not  have much effect, so we selected to study nor 
adrenaline levels before and after pneumoperitoneum. In both study group and 
the control group, we studied the noradrenlaine levels before 
pneumoperitoneum and 10 minutes after induction of pneumoperitoneum. 
 In the control group (group A) the 10 minutes serum noradrenaline 
values were significantly higher than the pre pneumoperitneal values. This is 
similar to the studies conducted by Loris et al,
 (26)
 Lee et al,
 (27)
 Jens fromholt 
Larsen et al 
(29)
 on hemodynamic response of pneumoperitoneum.  
In the study group (group B), where patients received 0.5μg/kg of 
dexmedetomidine as bolus dose over ten minutes before pneumoperitoneum,  
the noradrenaline levels taken 10 minutes after induction of pneumoperitoneum  
were significantly not increased when compared with the pre pneumoperitoneal 
values. Thus our study proved that the attenuation of arterial pressures by 
dexmedetomidine is due to suppression of catecholamines levels specifically 
noradrenaline by its central sympatholytic action. This is similar to studies 
conducted with dexmedetomidine by Pekka Talke et al
(21)
  in attenuation of 
stress response by dexmedetomidine in vascular surgeries, and H.A.Mowafi et 
al 
(23)
 in attenuation of ocular pressure changes by dexmedetomidine. 
Prolonged intraoperative increases of 20 mm of Hg or more in mean 
arterial pressure can cause significant implications in cardiovascular system. It 
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can cause increase incidence of myocardial ischemia, infarction and death. So 
by attenuating these responses in laparoscopy surgeries, dexmedetomidine may 
be of immense use in decreasing the morbidity in high risk cardiac patients. Our 
study concludes that dexmedetomidine can definitely be used for the attenuation 
of the hemodynamic responses arising due to CO2 pneumoperitoneum. 
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SUMMARY 
In our study,  
 We observed, that the systolic, diastolic and mean arterial pressure 
increased abruptly after induction of pneumoperitoneum  and this 
response sustained during the entire pneumoperitoneum period in the 
control group( group A). 
 We observed that in the dexmedetomidine group( group B) hemodynamic 
responses to the induction of pneumoperitoneum were effectively blunted 
and the heart rate and blood pressure levels when compared to the control 
group( group A). 
 In the control group (group A) the 10 minute serum noradrenaline values 
were significantly higher than the pre pneumoperitoneal values 
suggesting that all these hemodynamic changes are due to release of 
catecholamines. 
 In the study group (group B),  the noradrenaline levels taken 10 minutes 
after induction of pneumoperitoneum  were significantly not increased 
when compared with the pre pneumoperitoneal values suggesting that 
dexmedetomidine effectively suppressed the hemodynamic responses by 
its central sympatholytic action. 
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CONCLUSION 
We conclude that intravenous administration of dexmedetomidine as an 
adjunct before induction of CO2 pneumoperitoneum in laparoscopic 
cholecyctectomy effectively attenuates the arterial pressure increase arising due 
to pneumoperitoneal response  by suppressing the catecholamine release.  
 
 
  
84 
 
REFERENCES 
1. Hirvonen EA, Nuutinen LS, Kauko M: Hemodynamic changes due to 
Trendelenburg positioning and pneumoperitoneum during laparoscopic 
hysterectomy. Acta Anaesthesiol Scand 1995; 39:949. 
2. Walder AD, Aitkenhead AR: Role of vasopressin in the haemodynamic 
response to laparoscopic cholecystectomy. Br J Anaesth 1997; 78:264. 
3. Dorsay DA, Green FL, Baysinger CL: Hemodynamic changes during 
laparoscopic cholecystectomy monitored with transesophageal 
echocardiography. Surg Endosc 1995; 9:128. 
4. Hirvonen EA, Nuutinen LS, Vuolteenaho O: Hormonal responses and 
cardiac filling pressures in head-up or head-down position and 
pneumoperitoneum in patients undergoing operative laparoscopy. Br J 
Anaesth 1997; 78:128. 
5. Mann C, Boccara G, Pouzeratte Y, et al: The relationship among carbon 
dioxide pneumoperitoneum, vasopressin release, and hemodynamic 
changes. Anesth Analg 1999; 89:278. 
6. Melville RJ, Forsling ML, Frizis HI, et al: Stimulus for vasopressin 
release during elective intra-abdominal operations. Br J Surg 1985; 
72:979. 
85 
 
7. Laisalmi M, Koivusalo AM, Valta P, et al: Clonidine provides opioid-
sparing effect, stable hemodynamics, and renal integrity during 
laparoscopic cholecystectomy. Surg Endosc 2001; 15:1331. 
8. Bardoczky GI, Engelman E, Levarlet M, et al: Ventilatory effects of 
pneumoperitoneum monitored with continuous spirometry. Anaesthesia 
1993; 48:309. 
9. Rademaker BM, Odoom JA, de Wit LT, et al: Haemodynamic effects of 
pneumoperitoneum for laparoscopic surgery: a comparison of CO2 with 
N2O insufflation. Eur J Anaesthesiol 1994; 11:301 
10. Blobner M, Bogdanski R, Kochs E, et al: Effects of intraabdominally 
insufflated carbon dioxide and elevated intraabdominal pressure on 
splanchnic circulation: An experimental study in pigs. Anesthesiology 
1998; 89:475. 
11. Fujii Y, Tanaka H, Tsuruoka S, et al: Middle cerebral arterial blood flow 
velocity increases during laparoscopic cholecystectomy. Anesth Analg 
1994; 78:80. 
12. Menes T, Spivak H: Laparoscopy: Searching for the proper insufflation 
gas. Surg Endosc 2000; 14:1050. 
13. Guo TZ, Jiang JY, Buttermann AE, Maze M: Dexmedetomidine injection 
into the locus ceruleus produces antinociception. Anesthesiology 1996; 
84:873-881. 
86 
 
14. Ebert TJ, Hall JE, Barney JA, et al: The effects of increasing plasma 
concentrations of dexmedetomidine in humans. Anesthesiology 2000; 
93:382-394. 
15. Wallace AW, Galindez D, Salahieh A, et al: Effect of clonidine on 
cardiovascular morbidity and mortality after noncardiac surgery. 
Anesthesiology 2004; 101:284-293. 
16. Maccioli GA: Dexmedetomidine to facilitate drug withdrawal. 
Anesthesiology 2003; 98:575-577. 
17. Siobal MS, Kallet RH, Kivett VA, Tang JF: Use of dexmedetomidine to 
facilitate extubation in surgical intensive-care-unit patients who failed 
previous weaning attempts following prolonged mechanical ventilation: 
A pilot study. Respir Care 2006; 51:492-496. 
18. Aantaa R, Kanto J, Scheinin M, et al: Dexmedetomidine, an alpha 2-
adrenoceptor agonist, reduces anesthetic requirements for patients 
undergoing minor gynecologic surgery. Anesthesiology 1990; 73:230-
235. 
19. Grant SA, Breslin DS, MacLeod DB, et al: Dexmedetomidine infusion 
for sedation during fiberoptic intubation: A report of three cases. J Clin 
Anesth 2004; 16:124-126. 
20. Poonam S.Ghodki et al, studied dexmedetomidine as an anaesthetic 
adjuvant in laproscopic surgery: journal of Anaesthesiology clinical 
pharmacology 2012 
87 
 
21. Pekka Talke et al, Department of Anaesthesia, University of California : 
hemodynamic and adrenergic effects of perioperative effects of 
dexmedetomidine after vascular surgery: Anaesthesia and Analgesia 
22. Aho M, Scheinin M, Lehtinen AM, et al: Intramuscularly administered 
dexmedetomidine attenuates hemodynamic and stress hormone responses 
to gynecologic laparoscopy. Anesth Analg 1992; 75:932. 
23. H.A.Mowafi et al : the effect of dexmedetomidine premedication on intra 
ocular pressure changes after scoline and intubation: British Journal of 
Anaesthesia, 2008. 
24. Ahmed  Muktar et al, Department of medicine, Cairo University studied 
the use of dexmedetomidine in paediatric cardiac surgery 
25. Fredi  Menda et al, Department of Anaesthesia, yeditepe university, 
Turkey, the effect of using dexmedetomidine as an adjunct to attenuate 
hemodynamic response to endotracheal intubation in patients undergoing 
Fast trach CABG: Annals of cardiac Anaesthesia 
26. Joris JL, Chiche JD, Canivet JL, et al: Hemodynamic changes induced by 
laparoscopy and their endocrine correlates: Effects of clonidine. J Am 
Coll Cardiol 1998; 32:1389. 
27. D.Jee et al, the effect of intravenous magnesium sulphate attenuates 
arterial pressure increase during laproscopic cholcystectomy : British 
Journal of Anaesthesia 2009: 484-9  
88 
 
28. K. Myre et al :effect of high dose remifentanyl(0.39 μg/kg/min) infusion 
in attenuating the stress response to pneumoperitoneum in 18 patients 
undergoing laproscopic fundoplication : in Acta Anaesthesiologica 
Scandinavia, march 2003  
29. Jens fromholt Larsen et al, studied the effect of stress response of gasless 
and carbondioxide pneumoperitoneum:  Journal of Gasteroenterolgy 
surgery 2002. 
30. Gopta.k et al in :the effect of oral pregabalin (150mg) and oral Clonidine 
(200μg) for hemodynamic stability during laryngoscpy and laproscopic 
cholecystectomy : Saudi Journal of Amaesthesiology 2011. 
31. Tripathi DC et al, two different doses of intravenous Clonidine( 1μg/kg 
and 2μg/kg) in attenuating hemodynamic stress response during 
laproscopic cholecystectomy :  Journal of Anaesthesiology clinical 
pharmacology october 2011. 
32. Maharajan SK : the effect of propanalol in decreasing stress response in 
laproscopic cholecystectomy : Kattmandu University Medical Journal 
2005. 
 
 
 
 
 
89 
 
    PROFORMA 
Name:         I.P.No: 
Age:    Sex:     Weight: 
Pre Op Details: 
Investigations: 
Group: Study/ Control 
Time Of Induction: 
Time Of Start Of Surgery: 
Time Of End Of Surgery: 
Time Of Extubation: 
Total Duration Of Anaesthesia: 
Total Duration Of Surgery: 
 Hr Systolic Diastolic Mean Etco2 IAP 
Pre       
P 0       
P 5       
P 10       
P20       
P 30       
P 45       
Post       
Nor Adrenaline Values 
Prepneumoperitoneum – 
10 Minutes Pneumoreitoneum-  
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PATIENT CONSENT FORM  
“To Determine The Effect Of Dexmedetomidine In 
Attenuating Arterial Pressure Increase During 
Laparoscopic Cholecystectomy” 
Study Centre : Department of Anaesthesiology & Critical Care, Kilpauk 
Medical College.  
Participant Name :    Age :     Sex :  
O.P. No :  
 
 I ,confirm that I have understood the purpose of procedure for the above 
study. I had the opportunity to ask the question and all my questions and doubts 
have been answered to my satisifaction.  
 I have been explained about  the pitfall in the procedure and the 
management of it. I have been explained about the safety, advantages and 
disadvantages of the techniques. 
 I understand that my participation in the study is voluntary and that I am 
free to withdraw at anytime without giving any reason.  
I understand that investigator, regulatory authorities and the ethics 
committee will not need my permission to look at my health records both in 
respect to current study and any further research that may be conducted in 
relation to it, even if I withdraw from the study.  
 I understand that my identity will not  be revealed in any information 
released to third parties or published, unless as required under the law. I agree 
not to restrict the use of any data or results that arise from the study.  
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 I hereby consent to participate in this study of ―To Determine The Effect 
Of Dexmedetomidine In Attenuating Arterial Pressure Increase During 
Laparoscopic Cholecystectomy‖ 
 
Name of the patient :   Signature / thumb impression of patient :  
 
Name of the witness :   Signature :  
 
Address :     Contact Number :  
 
Name of the Investigator :   Signature :  
 
Time :     Date :  
 
Place :  
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                                                                                                         MASTER CHART – CONTROL GROUP  
name sex age height weight 
dur of 
sx 
dur of 
Ax 
PR Pre 
op 
sys Pre 
op 
dia 
Preop 
mean 
Preop PR P0 sys P0 dia P0 
mean 
P0 
rajammal F 48 156 53 34 57 86 111 74 84 70 103 78 84 
sekar M 50 167 68 37 58 84 112 76 85 74 104 78 84 
antony M 42 170 70 40 62 84 123 74 92 72 103 78 84 
kumari F 40 158 66 43 70 86 123 74 92 84 103 78 84 
arokiaraj M 52 165 75 45 75 86 123 74 92 84 106 74 84 
ramkumar M 56 166 72 42 73 90 127 71 94 72 103 78 84 
darun M 54 174 78 36 60 76 97 54 68 88 102 70 86 
durgadevi F 53 160 62 32 66 92 102 57 71 91 101 70 88 
renuka F 38 155 65 30 54 67 93 61 75 90 104 77 89 
rajalakshmi F 42 159 58 37 72 99 117 69 84 104 120 77 90 
ellappan M 48 160 64 38 69 102 100 58 70 104 106 70 86 
akbar M 47 169 65 40 77 76 97 54 68 88 102 70 86 
santhakumari F 54 154 59 42 74 92 100 61 76 93 134 90 104 
mary F 50 162 67 44 69 102 100 59 71 102 105 72 85 
anburaj M 52 172 80 45 74 76 98 54 69 89 100 68 86 
sankari F 56 158 59 42 72 87 121 76 90 92 112 78 88 
swaminathan M 47 171 84 37 64 102 102 58 72 104 106 70 86 
rajiv M 45 178 80 38 66 102 100 58 70 104 106 70 86 
vasudevan M 39 165 70 40 68 76 97 54 68 88 102 70 86 
yuvarani F 51 155 61 43 70 92 102 57 71 91 101 70 88 
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                                                                                                         MASTER CHART – CONTROL GROUP 
  
PR 
P5 
sys 
P5 
dia 
P5 
mean 
P5 
PR 
P10 
sys 
P10 
dia 
P10 
mean 
P10 
PR 
P20 
sys 
P20 
dia 
P20 
mean 
P20 
PR 
P30 
sys 
P30 
dia 
P30 
mean 
P30   
prepneumo 
NA 
10 
min 
NA 
81 126 84 106 76 134 90 107 76 128 85 100 70 114 76 92   220 510 
80 126 86 106 78 134 90 107 78 126 85 100 75 116 70 93   197 474 
81 128 86 104 77 137 91 108 71 129 87 100 70 114 76 92   178 460 
81 126 84 104 78 135 90 108 79 128 87 100 70 114 76 92   210 490 
80 126 84 104 79 134 90 108 80 128 87 100 74 116 78 92   170 446 
81 128 86 104 77 137 91 108 71 129 86 100 70 113 86 94   190 464 
80 103 78 88 79 118 86 94 90 114 84 100 81 116 86 99   226 506 
93 119 84 92 89 125 86 93 94 123 90 96 90 117 84 92   184 478 
78 102 73 88 79 119 85 97 77 110 80 94 79 104 75 89   204 494 
93 131 97 112 102 134 97 111 100 134 92 105 97 137 94 107   217 507 
93 120 85 97 103 132 100 116 98 130 104 115 98 133 100 112   182 490 
80 103 78 88 79 118 86 94 90 114 84 100 81 116 86 99   196 471 
89 131 97 112 102 134 102 115 102 114 84 100 100 116 84 98   211 504 
94 120 85 97 101 131 103 117 98 132 104 117 98 133 100 112   230 522 
80 103 78 88 79 105 76 89 88 114 84 100 81 118 86 101   180 450 
84 128 86 104 88 132 90 106 88 127 90 103 86 124 90 100   206 510 
93 123 85 98 103 132 100 116 98 130 104 115 98 133 100 112   199 484 
93 120 85 97 103 132 100 116 98 130 104 115 98 133 100 112   211 450 
80 103 78 88 79 118 86 94 90 114 84 100 81 116 86 99   172 420 
93 119 84 92 89 125 86 93 94 123 90 96 90 117 84 92   226 490 
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                                                                                                         MASTER CHART – STUDY GROUP 
  
name sex age height weight 
dur of 
sx 
dur of 
Ax 
PR Pre 
op 
sys Pre 
op 
dia 
Preop 
mean 
Preop PR P0 sys P0 dia P0 
mean 
P0 
santhakumar M 49 161 65 43 72 78 97 54 68 80 100 68 86 
ramadevi F 53 153 63 42 65 79 98 54 68 80 100 68 86 
saroja F  56 159 68 45 68 84 112 76 85 74 104 74 82 
lakshmi F 55 160 72 39 67 86 111 74 84 70 103 78 84 
shenbagavalli F 43 155 64 35 72 76 96 54 68 74 100 68 84 
kumar M 47 175 80 32 66 88 124 74 92 78 103 76 83 
hariharan M 39 174 78 37 64 92 100 61 76 87 103 72 84 
ashokan M 47 172 72 45 74 84 97 52 68 74 102 70 86 
ambika F 46 165 70 36 67 90 123 74 92 84 106 74 84 
anbukarasu M 50 168 68 42 75 94 125 72 92 84 103 78 84 
malar F 52 179 82 42 74 82 123 74 92 72 102 78 94 
senthilnathan M 54 166 72 36 66 90 11 74 84 84 105 78 85 
kanchana F 53 157 64 35 65 88 123 71 90 72 105 78 86 
srinivasan M 48 164 70 40 70 84 112 76 85 74 104 74 82 
krishnan M 46 173 77 38 61 92 100 61 76 80 116 84 98 
padmavathy F 45 170 73 45 76 86 112 74 84 72 103 78 84 
babu M 56 166 74 42 73 88 124 74 92 78 103 76 83 
ramoorthy M 51 163 66 41 69 84 97 52 68 74 104 70 87 
sudharshan M 43 167 71 46 75 90 11 74 84 84 105 78 85 
kannagidevi F 48 157 54 37 65 88 123 71 90 72 105 80 86 
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                                                                                                         MASTER CHART – STUSY GROUP 
 
 
PR 
P5 
sys 
P5 
dia 
P5 
mean 
P5 
PR 
P10 
sys 
P10 
dia 
P10 
mean 
P10 
PR 
P20 
sys 
P20 
dia 
P20 
mean 
P20 
PR 
P30 
sys 
P30 
dia 
P30 
mean 
P30   
prepneumo 
NA 
10 
min 
NA 
70 103 78 88 70 104 76 89 76 110 84 98 80 114 84 100   199 304 
80 104 78 89 84 104 70 88 76 110 84 98 80 114 86 101   211 302 
72 108 76 84 70 106 78 85 70 114 76 92 80 128 85 104   187 284 
72 108 72 86 76 106 76 84 74 114 76 92 80 116 76 93   178 302 
76 103 78 88 79 105 76 89 80 112 84 98 81 118 86 91   224 310 
76 110 74 84 72 128 74 94 77 113 86 94 78 129 86 100   198 320 
80 106 78 90 79 103 78 88 78 114 84 100 80 116 84 98   190 292 
72 103 78 88 68 106 80 90 68 110 76 86 66 114 82 99   234 422 
70 108 72 83 68 107 74 84 68 116 78 92 66 118 78 92   164 278 
81 126 84 104 76 125 70 92 74 128 87 100 70 114 76 92   172 270 
81 110 72 86 70 114 76 92 69 112 73 89 68 110 73 89   204 303 
78 112 72 84 76 110 72 84 74 114 85 92 74 126 84 106   222 307 
70 103 78 84 72 113 86 94 60 120 86 98 67 128 56 104   193 289 
72 108 76 84 70 106 78 85 70 114 77 93 89 128 85 107   187 294 
82 114 84 100 82 113 86 100 75 126 78 98 79 131 97 112   178 278 
72 109 72 86 75 106 76 84 74 120 76 92 80 116 76 93   167 311 
76 110 74 84 72 128 74 94 77 113 86 94 78 129 86 100   218 298 
72 103 78 83 68 108 80 92 68 112 76 87 66 114 82 99   180 298 
78 114 72 86 76 110 72 84 74 116 85 94 74 126 84 106   217 300 
70 108 78 88 72 114 86 94 60 120 86 98 67 128 56 104   172 284 
